Frequency of E coli and its sensitivity to nitrofurantion in patients with urinary tract infection
Article Sidebar
Main Article Content
Abstract
Background: Urinary tract infection (UTI) is one of the most common bacterial illnesses in adults and is one of the most common indications for antibiotics. This study is conducted to determine frequency of E-Coli and its sensitivity to nitrofurantoin in patients with urinary tract infection.
Materials and Methods: The study was conducted at a tertiary care hospital of District Peshawar, i.e. Khyber Teaching Hospital (KTH), after reviewed and approved by the Committee for Ethical Review of Research involving Human Subjects of KTH. Non-random consecutive sampling technique was used for the collection of data and data collection was completed in 06 months’ time i.e. from 20th February to 19th August 2018. The survey was conducted as a descriptive cross-sectional study using open Epi calculator, keeping confidence interval of 95%, sample size calculated is 148. Urine samples were collected in sterile containers and was sent to laboratory for routine examination, culture and sensitivity. A colony 105 or more was considered E Coli growth. Nitrofurantoin was used to check the sensitivity for organisms as per operational definition. All the tests and examinations were carried out under the supervision of experienced medical specialist and microbiologist.
RESULTS: In this study, 148 patients were studied. Average age was 41.86 years + 11.62SD. E coli was found in 91(61.5%) of patients out of total 148 patients. Among UTI patients 78(85.7%) were sensitive to Nitrofurantoin.
CONCLUSION: High prevalence of drug-resistant urinary tract pathogens, particularly to Nitrofurantoin suggests cautious use of antibiotic therapy for the treatment of UTI
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.
